Mounjaro Tirzepatide Injection
  1. Home
  2. Mounjaro
  3. Mounjaro Tirzepatide Injection

Mounjaro Tirzepatide Injection

Mounjaro Tirzepatide Injection is a prescription injectable medication supplied in a prefilled, multi-dose injection pen for improving glycemic control in adults with type 2 diabetes and for chronic weight management where approved. It delivers accurate once-weekly subcutaneous dosing through a convenient, ready-to-use injection system. The ergonomic pen supports simple administration and long-term treatment adherence.

BUY NOW

Category

Mounjaro Tirzepatide Injection contains tirzepatide, a dual GIP and GLP-1 receptor agonist that helps improve blood glucose control by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The multi-dose prefilled pen is engineered to provide precise once-weekly dosing with minimal preparation, making routine therapy more convenient for both patients and healthcare providers. Manufactured under stringent pharmaceutical quality standards, each pen is supplied sterile for single-patient use. Mounjaro should be administered only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Mounjaro Tirzepatide Injection
Active Ingredient Tirzepatide
Dosage Form Prefilled Multi-Dose Injection Pen
Route of Administration Subcutaneous Injection
Dosing Frequency Once Weekly (As Prescribed)
Storage Refrigerated at 2°C–8°C before first use

Product Also Known As

Mounjaro Tirzepatide Injection, Mounjaro Injection Pen, Tirzepatide Injection, Tirzepatide Pre-filled Pen, Mounjaro Multi-Dose Pen, Dual GIP GLP-1 Injection, Weekly Tirzepatide Injection